Avdoralimab ( DrugBank: Avdoralimab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
162	類天疱瘡（後天性表皮水疱症を含む。）	2

162. 類天疱瘡（後天性表皮水疱症を含む。）

臨床試験数 : 83 / 薬物数 : 128 - (DrugBank : 51) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 142

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04563923 (ClinicalTrials.gov)	October 10, 2020	17/9/2020	Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody	Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody	Bullous Pemphigoid	Drug: Avdoralimab (IPH5401);Other: Control	Centre Hospitalier Universitaire de Nice	NULL	Recruiting	18 Years	N/A	All	40	Phase 2	France
2	EUCTR2020-002912-34-FR (EUCTR)	11/08/2020	22/06/2020	Treatment of bullous pemphigoid with avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody	Treatment of bullous pemphigoid with avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody - PB	Auto Immune bullous Diseases;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C ...	Product Name: avdoralimab Product Code: IPH5401 INN or Proposed INN: avdoralimab Other descriptive name ...	CHU NICE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France

First Previous1Next Last